Percutaneous endocardial transfer and expression of genes to the myocardium utilizing fluoroscopic guidance

Timothy A. Sanborn, Neil R. Hackett, Leonard Y. Lee, Tarek El-Sawy, Irene Blanco, Norman Tarazona, Ezra Deutsch, Ronald G. Crystal, Todd K. Rosengart

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Experimental studies indicate that administration of angiogenic proteins or genes by the epicardial or intracoronary route can stimulate development of new collateral vessels and improve myocardial perfusion. An endocardial catheter-based approach to this therapy would obviate the need for surgery, while preserving the effectiveness of direct intramyocardial administration. Fluoroscopic guidance and prototype, preformed, coaxial catheters were used to examine the feasibility of percutaneous catheter-based adenovirus (Ad)-mediated gene transfer and expression in normal swine myocardium. The feasibility of intramyocardial administration (100 μl/injection) of a radiocontrast agent and black tissue dye to all regions of the left ventricle (septum, anterior, lateral, and inferior wall) was confirmed fluoroscopically and on postmortem examination. Injections of replication-deficient adenovirus (10 injections of 1011 particle units/100 μl each) coding for β-galactosidase (Adβgal) or vascular endothelial growth factor (AdGVVEGF121.10) were administered to the left ventricular free wall to examine endocardial based gene transfer and expression. β-Galactosidase activity was detected by histochemical staining and quantitative assay in targeted regions of the myocardium. Regional VEGF expression was found to be significantly greater in targeted regions (1.3 ± 0.4 ng/mg protein) as compared with non-targeted regions (0.3 ± 0.1 ng/mg protein) or regions injected with control (Adβgal) virus (0.2 ± 0.03 ng/mg protein, P < 0.001). Catheter-based Ad mediated endocardial gene transfer and expression is feasible using percutaneous, fluoroscopically guided, preformed, coaxial catheters. This approach should be clinically useful to administer angiogenic genes to the ischemic myocardium.

Original languageEnglish (US)
Pages (from-to)260-266
Number of pages7
JournalCatheterization and Cardiovascular Interventions
Volume52
Issue number2
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Myocardium
Catheters
Gene Expression
Adenoviridae
Galactosidases
Vascular Endothelial Growth Factor A
Injections
Angiogenic Proteins
Proteins
Contrast Media
Genes
Heart Ventricles
Autopsy
Coloring Agents
Swine
Perfusion
Staining and Labeling
Viruses
Therapeutics

Keywords

  • Angiogenesis
  • Catheter
  • Fluoroscopy
  • Gene therapy
  • Myocardium

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Percutaneous endocardial transfer and expression of genes to the myocardium utilizing fluoroscopic guidance. / Sanborn, Timothy A.; Hackett, Neil R.; Lee, Leonard Y.; El-Sawy, Tarek; Blanco, Irene; Tarazona, Norman; Deutsch, Ezra; Crystal, Ronald G.; Rosengart, Todd K.

In: Catheterization and Cardiovascular Interventions, Vol. 52, No. 2, 2001, p. 260-266.

Research output: Contribution to journalArticle

Sanborn, Timothy A. ; Hackett, Neil R. ; Lee, Leonard Y. ; El-Sawy, Tarek ; Blanco, Irene ; Tarazona, Norman ; Deutsch, Ezra ; Crystal, Ronald G. ; Rosengart, Todd K. / Percutaneous endocardial transfer and expression of genes to the myocardium utilizing fluoroscopic guidance. In: Catheterization and Cardiovascular Interventions. 2001 ; Vol. 52, No. 2. pp. 260-266.
@article{de12ca0c07fc4ff5a0524093c4662e40,
title = "Percutaneous endocardial transfer and expression of genes to the myocardium utilizing fluoroscopic guidance",
abstract = "Experimental studies indicate that administration of angiogenic proteins or genes by the epicardial or intracoronary route can stimulate development of new collateral vessels and improve myocardial perfusion. An endocardial catheter-based approach to this therapy would obviate the need for surgery, while preserving the effectiveness of direct intramyocardial administration. Fluoroscopic guidance and prototype, preformed, coaxial catheters were used to examine the feasibility of percutaneous catheter-based adenovirus (Ad)-mediated gene transfer and expression in normal swine myocardium. The feasibility of intramyocardial administration (100 μl/injection) of a radiocontrast agent and black tissue dye to all regions of the left ventricle (septum, anterior, lateral, and inferior wall) was confirmed fluoroscopically and on postmortem examination. Injections of replication-deficient adenovirus (10 injections of 1011 particle units/100 μl each) coding for β-galactosidase (Adβgal) or vascular endothelial growth factor (AdGVVEGF121.10) were administered to the left ventricular free wall to examine endocardial based gene transfer and expression. β-Galactosidase activity was detected by histochemical staining and quantitative assay in targeted regions of the myocardium. Regional VEGF expression was found to be significantly greater in targeted regions (1.3 ± 0.4 ng/mg protein) as compared with non-targeted regions (0.3 ± 0.1 ng/mg protein) or regions injected with control (Adβgal) virus (0.2 ± 0.03 ng/mg protein, P < 0.001). Catheter-based Ad mediated endocardial gene transfer and expression is feasible using percutaneous, fluoroscopically guided, preformed, coaxial catheters. This approach should be clinically useful to administer angiogenic genes to the ischemic myocardium.",
keywords = "Angiogenesis, Catheter, Fluoroscopy, Gene therapy, Myocardium",
author = "Sanborn, {Timothy A.} and Hackett, {Neil R.} and Lee, {Leonard Y.} and Tarek El-Sawy and Irene Blanco and Norman Tarazona and Ezra Deutsch and Crystal, {Ronald G.} and Rosengart, {Todd K.}",
year = "2001",
doi = "10.1002/1522-726X(200102)52:2<260::AID-CCD1061>3.0.CO;2-T",
language = "English (US)",
volume = "52",
pages = "260--266",
journal = "Catheterization and Cardiovascular Interventions",
issn = "1522-1946",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Percutaneous endocardial transfer and expression of genes to the myocardium utilizing fluoroscopic guidance

AU - Sanborn, Timothy A.

AU - Hackett, Neil R.

AU - Lee, Leonard Y.

AU - El-Sawy, Tarek

AU - Blanco, Irene

AU - Tarazona, Norman

AU - Deutsch, Ezra

AU - Crystal, Ronald G.

AU - Rosengart, Todd K.

PY - 2001

Y1 - 2001

N2 - Experimental studies indicate that administration of angiogenic proteins or genes by the epicardial or intracoronary route can stimulate development of new collateral vessels and improve myocardial perfusion. An endocardial catheter-based approach to this therapy would obviate the need for surgery, while preserving the effectiveness of direct intramyocardial administration. Fluoroscopic guidance and prototype, preformed, coaxial catheters were used to examine the feasibility of percutaneous catheter-based adenovirus (Ad)-mediated gene transfer and expression in normal swine myocardium. The feasibility of intramyocardial administration (100 μl/injection) of a radiocontrast agent and black tissue dye to all regions of the left ventricle (septum, anterior, lateral, and inferior wall) was confirmed fluoroscopically and on postmortem examination. Injections of replication-deficient adenovirus (10 injections of 1011 particle units/100 μl each) coding for β-galactosidase (Adβgal) or vascular endothelial growth factor (AdGVVEGF121.10) were administered to the left ventricular free wall to examine endocardial based gene transfer and expression. β-Galactosidase activity was detected by histochemical staining and quantitative assay in targeted regions of the myocardium. Regional VEGF expression was found to be significantly greater in targeted regions (1.3 ± 0.4 ng/mg protein) as compared with non-targeted regions (0.3 ± 0.1 ng/mg protein) or regions injected with control (Adβgal) virus (0.2 ± 0.03 ng/mg protein, P < 0.001). Catheter-based Ad mediated endocardial gene transfer and expression is feasible using percutaneous, fluoroscopically guided, preformed, coaxial catheters. This approach should be clinically useful to administer angiogenic genes to the ischemic myocardium.

AB - Experimental studies indicate that administration of angiogenic proteins or genes by the epicardial or intracoronary route can stimulate development of new collateral vessels and improve myocardial perfusion. An endocardial catheter-based approach to this therapy would obviate the need for surgery, while preserving the effectiveness of direct intramyocardial administration. Fluoroscopic guidance and prototype, preformed, coaxial catheters were used to examine the feasibility of percutaneous catheter-based adenovirus (Ad)-mediated gene transfer and expression in normal swine myocardium. The feasibility of intramyocardial administration (100 μl/injection) of a radiocontrast agent and black tissue dye to all regions of the left ventricle (septum, anterior, lateral, and inferior wall) was confirmed fluoroscopically and on postmortem examination. Injections of replication-deficient adenovirus (10 injections of 1011 particle units/100 μl each) coding for β-galactosidase (Adβgal) or vascular endothelial growth factor (AdGVVEGF121.10) were administered to the left ventricular free wall to examine endocardial based gene transfer and expression. β-Galactosidase activity was detected by histochemical staining and quantitative assay in targeted regions of the myocardium. Regional VEGF expression was found to be significantly greater in targeted regions (1.3 ± 0.4 ng/mg protein) as compared with non-targeted regions (0.3 ± 0.1 ng/mg protein) or regions injected with control (Adβgal) virus (0.2 ± 0.03 ng/mg protein, P < 0.001). Catheter-based Ad mediated endocardial gene transfer and expression is feasible using percutaneous, fluoroscopically guided, preformed, coaxial catheters. This approach should be clinically useful to administer angiogenic genes to the ischemic myocardium.

KW - Angiogenesis

KW - Catheter

KW - Fluoroscopy

KW - Gene therapy

KW - Myocardium

UR - http://www.scopus.com/inward/record.url?scp=0035146807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035146807&partnerID=8YFLogxK

U2 - 10.1002/1522-726X(200102)52:2<260::AID-CCD1061>3.0.CO;2-T

DO - 10.1002/1522-726X(200102)52:2<260::AID-CCD1061>3.0.CO;2-T

M3 - Article

VL - 52

SP - 260

EP - 266

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

SN - 1522-1946

IS - 2

ER -